Center Laboratories : Explanation of the difference between the self -closing declarations of related party transactions and the audited review by CPA for the fourth quarter of 2021
Explanation of the difference between the self
-closing declarations of related party transactions and
the audited review by CPA for the fourth quarter of 2021
Date of events
2022/04/13
To which item it meets
paragraph 53
Statement
1.Date of occurrence of the event:2022/04/13
2.Company name:CENTER LABORATORIES,INC.
3.Relationship to the Company (please enter "head office" or
"subsidiaries"):head office
4.Reciprocal shareholding ratios:NA
5.Cause of occurrence:
In the fourth quarter of 2021, the assets acquired by the company's
related parties were $0, and the financial audit was $86,880,000.
This was due to the company's accountant's justification on CS02
diabetes new drug for China market authorization obtained in 2021.
This equity was acquired by a 100%-owned subsidiary company,
Centerlab Investment Holding Limited, and directly invested in
Guangdong PinSheng Pharmaceutical Technology Co., Ltd., considering
RMB 20,000,000 (NTD$86,880,000).
6.Countermeasures:
To report the reasons for the discrepancies on the Market Observation
Post System under the section of 「Explanation of the numerals
differences between the filing of related parties transaction and
audit review by an accountant」.
7.Any other matters that need to be specified:None
Attachments
Original Link
Original Document
Permalink
Disclaimer
Center Laboratories Inc. published this content on 13 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 April 2022 10:34:14 UTC.
Center Laboratories, Inc. is a Taiwan-based company principally engaged in the production, marketing and distribution of infant nutrition products, as well as the research and development, processing, production, packaging, marketing and sales of dairy products. The Company's main products include dairy products and probiotic products. The Company is also involved in the manufacture, wholesale and retail of western medicines. The Company distributes its products in the domestic market and to overseas markets.
Center Laboratories : Explanation of the difference between the self -closing declarations of related party transactions and the audited review by CPA for the fourth quarter of 2021
CENTER LABORATORIES, INC. 
